missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ CY 09

Catalog No. 18791108
Ansicht ändern
Click to view available options
Menge:
10 mg
50 mg
Packungsgröße:
10 Milligramm
50 Milligramm
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Menge Packungsgröße
18791108 50 mg 50 Milligramm
18783198 10 mg 10 Milligramm
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen
Catalog No. 18791108 Lieferant R&D Systems™ Lieferanten-Nr. 6436/50
 Eingeschränkter Artikel
Estimated Shipment: 27-11-2026
Zum Warenkorb hinzufügen
Add to basket

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

A Tocris product, part of R&D Systems. Inflammasomes Inhibitors

CY 09 is a NLRP3 inhibitor (Kd = 500 nM); directly binds to ATP-binding motif of NLRP3 NACHT domain. Blocks NLRP3 inflammasome assembly and activation. Displays therapeutic effects on mouse models of cryopyrin-associated autoinflammatory syndrome (CAPS) and type 2 diabetes. Exhibits no activity for hERG (10 μM).
TRUSTED_SUSTAINABILITY

Specifications

Chemischer Name oder Material 4-[[4-Oxo-2-thioxo-3-[[3-(trifluoromethyl)phenyl]methyl]-5-thiazolidinylidene]methyl]benzoic acid
CAS 1073612-91-5
Menge 50 mg
Produktlinie Tocris
Summenformel C19H12F3NO3S2
Reinheit 98%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.